7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one CAS: 148870-57-9

Get Quote

Product Parameters
Catalog No.	BK8YQ4
CAS.RN	148870-57-9
Molecular Formula	C15H18INO3
Molecular Weight	387.21 g/mol
Purity	NLT 98%

Product Overview

7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzozazepine-2-one is a structurally complex pharmaceutical intermediate widely used in the construction and synthesis of novel drug molecules. This compound possesses a well-defined chemical structure and stable functional group characteristics, making it suitable for key stages in organic synthesis, drug development, and process development. It can meet diverse customer needs in small-scale, pilot-scale, and industrial-scale production during the R&D phase, and is an important precursor for the synthesis of drugs containing benzozazepine skeletons, applicable to the R&D and production processes of various innovative and generic drugs.

Applications

Drug molecule construction and synthesis
Customized intermediate preparation
Process route development and optimization
Support for innovative drug R&D projects
Chemically patent-protected synthesis

Quality & Supply Capability

English Name: 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one Properties: This product is a white to off-white solid containing two methoxy substituents and one iodopropyl side chain. It exhibits good chemical stability and reactivity, making it suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial-scale production, covering small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control requirements, packaging specifications, and delivery cycles according to customer needs, while providing complete quality documentation support. We also offer technical support from laboratory research and development to process scale-up, helping customers efficiently advance drug development and industrialization processes.

Why Choose Bioncan

Focused on pharmaceutical intermediates, possessing extensive synthesis experience and technological expertise. Full-scale supply capabilities, covering needs from laboratory to commercial production. Provides complete quality control documentation to ensure controllable and traceable product quality. Supports customized requirements, adjusting purity, impurity control, and packaging solutions as needed. Provides supporting process optimization and scale-up technologies to improve clients' R&D efficiency and commercialization success rates.

Intermediates of Ivabradine hydrochloride

Catalog No.	Product Name	CAS
BA05GW	Ivabradine hydrochloride API	148849-67-6
BK82Q4	4,5-Dimethoxy-1-cyanobenzocyclobutane	35202-54-1
BK598V	(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride	866783-13-3
BK33FJ	7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one	73942-87-7
BK56VJ	(S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine	866783-12-2
BK206L	Dehydro ivabradine	1086026-31-4
BK4YJ2	N-(3-Bromopropyl)-Phthalimide	5460-29-7
BK3E8G	2,2-Dimethoxy acetaldehyde	51673-84-8
BK40K6	1,1-Diethoxyethene	2678-54-8
BK9D07	The metabolite of ivabradine	215935-23-2
BK752T	3,4-DimethoxyPhenylethylamine	120-20-7
BK364P	C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE	73344-75-9
BK96F9	(3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester	148870-55-7
BK8YQ4	7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one	148870-57-9
BK7CK9	Propanedioic acid, 2-(2-bromo-4,5-dimethoxyphenyl)-, 1,3-dimethyl ester	1069115-30-5
BK1AT9	Bicyclo[4.2.0]octa-1,3,5-triene-7,7-dicarboxylic acid, 3,4-dimethoxy-, 7,7-dimethyl ester	1069115-32-7
BK9Z16	7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride	163629-94-5
BK813C	4,5-diMethoxy-N-Methyl-1,2-dihydrocyclobutabenzene-1-carboxaMide	1206230-27-4
BK2BU0	3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one	148870-58-0
BK2PD7	3-(3-(((S)-4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrochloride	1393427-01-4
BK5KH5	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one	1393427-02-5
BK45M1	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(2,2-dimethoxyethyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one	1393427-03-6
BK5EL6	(3,4-DiMethoxyphenyl)acetyl chloride	10313-60-7
BK8E10	7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)acetyl)(methyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one	1393427-04-7
BK2YU2	4,5-DIBROMOVERATROLE	37895-73-1
BK67FH	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1-oxide	1132079-01-6
BK2Z7N	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-1-ium chloride	1246638-10-7
BK0F52	Bicyclo[4.2.0]octa-1,3,5-triene-7-carboximidamide, 3,4-dimethoxy-N-methyl-N-[3-(1,2,4,5-tetrahydro-7,8-dimethoxy-2-oxo-3H-3-benzazepin-3-yl)propyl]-	1246672-58-1
BK8Q64	7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one	98062-25-0
BK85JV	3-chloro-N-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-N-methyl-1-propanamine	1031767-71-1
BK5F84	(S)-N-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methyl-3-(7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-3-yl)propan-1-aminium chloride	1325209-22-0
BK515P	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one sulfate	1325209-23-1
BK5J56	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one mesylate	1325209-25-3
BK32MX	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrobromide	1325209-24-2
BK1E79	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one phosphate	1325209-26-4
BK36R2	(S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate	1325209-27-5

Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 148870-57-9, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.

Company Name*

Name *

Email *

Quantity*

Message *

148870-57-9